PIK3CA-related overgrowth spectrum (PROS) presenting as isolated macrodactyly

被引:1
|
作者
Krishnamurthy, Kritika [1 ,4 ]
Edema, Ukuemi [1 ]
Ustun, Berrin [1 ,2 ]
Villanueva-Siles, Esperanza [1 ,2 ]
Koehler, Steven M. [2 ,3 ]
Naeem, Rizwan [1 ,2 ]
Wang, Yanhua [1 ,2 ]
Goldstein, Doctor Y. [1 ,2 ]
机构
[1] Montefiore Med Ctr, Dept Pathol, Bronx, NY 10467 USA
[2] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA
[3] Montefiore Med Ctr, Dept Orthoped Surg, Bronx, NY 10467 USA
[4] Montefiore Med Ctr, Dept Mol Pathol, 1635 Poplar St, Bronx, NY 10462 USA
来源
JOURNAL OF SURGICAL CASE REPORTS | 2023年 / 2023卷 / 10期
关键词
PIK3CA-related overgrowth spectrum; PROS; macrodactyly; PIK3CA; mTOR pathway; mTOR inhibitors;
D O I
10.1093/jscr/rjad549
中图分类号
R61 [外科手术学];
学科分类号
摘要
PIK3CA-related overgrowth spectrum (PROS) is a heterogeneous group of diseases, with varied clinical presentations ranging from isolated segmental overgrowths to megalencephaly and vascular malformations, all resulting from post-zygotic activating mutations in PIK3CA. Isolated macrodactyly of upper limb is extremely rare, accounting only for 0.9%-1% of all congenital anomalies of the upper limb. This report describes a case of congenital, isolated, nonprogressive macrodactyly of the right index finger and thumb, in an adult patient that was treated with debulking surgery. The microscopic features were compatible with lipomatosis of nerve. Due to the prompt and pertinent molecular testing, which identified a somatic PIK3CA variant, c.3140A > G, p.H1047R., the case was classified as a PROS. The availability of mTOR inhibitors offers additional treatment possibilities in cases with progressive disease. This case report highlights the importance of molecular testing to identify PROS, to further the knowledge of this continually expanding entity.
引用
收藏
页数:4
相关论文
共 37 条
  • [1] Phenotypic and molecular characterization of five patients with PIK3CA-related overgrowth spectrum (PROS)
    Ili, Ezgi Gokpinar
    Tasdelen, Elifcan
    Durmaz, Ceren Damla
    Altiner, Sule
    Tuncali, Timur
    Martinez-Glez, Victor
    Karabulut, Halil Gurhan
    Vural, Secil
    Ceylaner, Serdar
    Acar, Mustafa Oguz
    Ruhi, Hatice Ilgin
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2022, 188 (06) : 1792 - 1800
  • [2] Updates on Diagnosis and Treatment of PIK3CA-Related Overgrowth Spectrum
    Chen, Hongrui
    Gao, Wei
    Liu, Hongyuan
    Sun, Bin
    Hua, Chen
    Lin, Xiaoxi
    ANNALS OF PLASTIC SURGERY, 2023, 90 (5S) : S209 - S215
  • [3] PIK3CA-Related Overgrowth Spectrum (PROS): Diagnostic and Testing Eligibility Criteria, Differential Diagnosis, and Evaluation
    Keppler-Noreuil, Kim M.
    Rios, Jonathan J.
    Parker, Victoria E. R.
    Semple, Robert K.
    Lindhurst, Marjorie J.
    Sapp, Julie C.
    Alomari, Ahmad
    Ezaki, Marybeth
    Dobyns, William
    Biesecker, Leslie G.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2015, 167 (02) : 287 - 295
  • [4] FDA Approval Summary: Alpelisib for PIK3CA-Related Overgrowth Spectrum
    Singh, Sonia
    Bradford, Diana
    Li, Xiaoxue
    Mishra-Kalyani, Pallavi S.
    Shen, Yuan-Li
    Wang, Lingshan
    Zhao, Hong
    Xiong, Ye
    Liu, Jiang
    Charlab, Rosane
    Kraft, Jeffrey
    Khasar, Sachia
    Miller, Claudia P.
    Rivera, Donna R.
    Kluetz, Paul G.
    Pazdur, Richard
    Beaver, Julia A.
    Singh, Harpreet
    Donoghue, Martha
    CLINICAL CANCER RESEARCH, 2024, 30 (01) : 23 - 28
  • [5] Clinical delineation and natural history of the PIK3CA-related overgrowth spectrum
    Keppler-Noreuil, Kim M.
    Sapp, Julie C.
    Lindhurst, Marjorie J.
    Parker, Victoria E. R.
    Blumhorst, Cathy
    Darling, Thomas
    Tosi, Laura L.
    Huson, Susan M.
    Whitehouse, Richard W.
    Jakkula, Eveliina
    Grant, Ian
    Balasubramanian, Meena
    Chandler, Kate E.
    Fraser, Jamie L.
    Gucev, Zoran
    Crow, Yanick J.
    Brennan, Leslie Manace
    Clark, Robin
    Sellars, Elizabeth A.
    Pena, Loren D. M.
    Krishnamurty, Vidya
    Shuen, Andrew
    Braverman, Nancy
    Cunningham, Michael L.
    Sutton, V. Reid
    Tasic, Velibor
    Graham, John M., Jr.
    Geer, Joseph, Jr.
    Henderson, Alex
    Semple, Robert K.
    Biesecker, Leslie G.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2014, 164 (07) : 1713 - 1733
  • [6] Delineation of the phenotypes and genotypes of PIK3CA-related overgrowth spectrum in East asians
    Chen, Hongrui
    Sun, Bin
    Liu, Hongyuan
    Gao, Wei
    Qiu, Yajing
    Hua, Chen
    Lin, Xiaoxi
    MOLECULAR GENETICS AND GENOMICS, 2024, 299 (01)
  • [7] Mapping the PIK3CA-related overgrowth spectrum (PROS) patient and caregiver journey using a patient-centered approach
    Rodriguez-Laguna, Lara
    Davis, Kristen
    Finger, Mellenee
    Aubel, Dawn
    Vlamis, Robin
    Johnson, Craig
    ORPHANET JOURNAL OF RARE DISEASES, 2022, 17 (01)
  • [8] One of the First Cases with PIK3CA-related Overgrowth Spectrum (PROS) in Saudi Arabia: A Case Report and Literature Review
    Alsaedi, Saleem A.
    Qurashi, Oday
    Bajunaid, Mohammed
    Altalhi, Abdullah A.
    Shawli, Aiman M.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (01)
  • [9] Mapping the PIK3CA-related overgrowth spectrum (PROS) patient and caregiver journey using a patient-centered approach
    Lara Rodríguez-Laguna
    Kristen Davis
    Mellenee Finger
    Dawn Aubel
    Robin Vlamis
    Craig Johnson
    Orphanet Journal of Rare Diseases, 17
  • [10] Kaposiform hemangioendothelioma further broadens the phenotype of PIK3CA-related overgrowth spectrum
    Carli, Diana
    Kalantari, Silvia
    Manicone, Rosaria
    Coppo, Paola
    di Celle, Paola Francia
    La Selva, Roberta
    Santoro, Federica
    Ranieri, Carlotta
    Cardaropoli, Simona
    Fagioli, Franca
    Ferrero, Giovanni Battista
    Resta, Nicoletta
    Mussa, Alessandro
    CLINICAL GENETICS, 2021, 100 (05) : 624 - 627